Titelia

Fund shareholders of Lavipharm SA

ISIN GRS246003008 · Greece · LEI 213800USC69CRPRGWJ15

Fund shareholders
5
Of which ETFs
2 3 other funds
Value held
350.2K $
FundSharesValueWeight in fund
EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC 161,049293.3K $0.00 %as of Apr 30, 2026 ↗
Emerging Markets Sustainability Core 1 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 13,88825.3K $0.00 %as of Apr 30, 2026 ↗
Dimensional Emerging Markets Core Equity 2 ETF Dimensional ETF Trust 10,83019.6K $0.00 %as of Apr 30, 2026 ↗
Emerging Markets Social Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 6,41211.7K $0.00 %as of Apr 30, 2026 ↗
Dimensional Emerging Markets ex China Core Equity ETF Dimensional ETF Trust 212383 $0.00 %as of Apr 30, 2026 ↗

Download this table: CSV, JSON

Report an error

The funds most exposed to it

The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.

FundWeight in fund
Emerging Markets Sustainability Core 1 Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 0.00 %as of Apr 30, 2026 ↗
EMERGING MARKETS CORE EQUITY 2 PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC 0.00 %as of Apr 30, 2026 ↗
Emerging Markets Social Core Equity Portfolio DFA INVESTMENT DIMENSIONS GROUP INC 0.00 %as of Apr 30, 2026 ↗
Dimensional Emerging Markets Core Equity 2 ETF Dimensional ETF Trust 0.00 %as of Apr 30, 2026 ↗
Dimensional Emerging Markets ex China Core Equity ETF Dimensional ETF Trust 0.00 %as of Apr 30, 2026 ↗

Quarter after quarter

Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.

QuarterShareholdersChangeSharesChange
2026Q25+1192,391+3.4 %
2026Q140185,9790.0 %
2025Q440185,9790.0 %
2025Q340185,9790.0 %
2025Q240185,9790.0 %
2025Q14+1185,979+0.1 %
2024Q430185,7670.0 %
2024Q330185,7670.0 %
2024Q23+2185,767+35.3 %
2024Q11137,328
Cite this page

Titelia. "Fund shareholders of Lavipharm SA". https://titelia.com/en/stocks/lavipharm-sa-GRS246003008